EQUASENS (EQS.PA) Stock Price, Forecast & Analysis
Europe - EPA:EQS - FR0012882389 - Common Stock
EQS.PA Key Statistics, Chart & Performance
The current stock price of EQS.PA is 41.15 EUR. In the past month the price increased by 3.58%. In the past year, price increased by 0.84%.
EQS.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| NXU.DE | NEXUS AG | 36.19 | 1.23B | ||
| GPI.MI | GPI SPA | 20.03 | 434.23M | ||
| ALCGM.PA | CEGEDIM SA | N/A | 171.31M | ||
| AGFB.BR | AGFA-GEVAERT NV | N/A | 97.07M | ||
| ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 103.36M | ||
| AJ91.DE | DOCCHECK AG | 11.54 | 60.84M | ||
| M3V.DE | MEVIS MEDICAL SOLUTIONS AG | 9.92 | 45.14M | ||
| ALINS.PA | INTRASENSE SAS | N/A | 13.55M | ||
| MLLAB.PA | MEDIA LAB SPA | N/A | 9.01M |
Related stock screener links
About EQS.PA
Company Profile
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );
Company Info
EQUASENS
5 Allee de Saint-Cloud
Villers-les-Nancy GRAND EST FR
Employees: 1271
Phone: 33383159595
EQUASENS / EQS.PA FAQ
What does EQUASENS do?
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );
What is the current price of EQS stock?
The current stock price of EQS.PA is 41.15 EUR. The price decreased by -1.91% in the last trading session.
Does EQS stock pay dividends?
EQUASENS (EQS.PA) has a dividend yield of 3%. The yearly dividend amount is currently 1.25.
How is the ChartMill rating for EQUASENS?
EQS.PA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists EQS stock?
EQS.PA stock is listed on the Euronext Paris - Matif exchange.
What do analysts say about EQUASENS (EQS.PA) stock?
6 analysts have analysed EQS.PA and the average price target is 49.98 EUR. This implies a price increase of 21.46% is expected in the next year compared to the current price of 41.15.
Is EQUASENS (EQS.PA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on EQS.PA.
EQS.PA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to EQS.PA. When comparing the yearly performance of all stocks, EQS.PA is a bad performer in the overall market: 82.59% of all stocks are doing better.
EQS.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA. EQS.PA has an excellent profitability rating, but there are some minor concerns on its financial health.
EQS.PA Financial Highlights
Over the last trailing twelve months EQS.PA reported a non-GAAP Earnings per Share(EPS) of 2.39. The EPS decreased by -14.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.15% | ||
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| Debt/Equity | 0.09 |
EQS.PA Forecast & Estimates
6 analysts have analysed EQS.PA and the average price target is 49.98 EUR. This implies a price increase of 21.46% is expected in the next year compared to the current price of 41.15.
For the next year, analysts expect an EPS growth of 13% and a revenue growth 9.72% for EQS.PA